231 related articles for article (PubMed ID: 10725957)
1. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
2. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
3. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hilus-cell hyperplasia and high serum testosterone in a patient with postmenopausal virilization.
Delibasi T; Erdogan MF; Serinsöz E; Kaygusuz G; Erdogan G; Sertçelik A
Endocr Pract; 2007 Sep; 13(5):472-5. PubMed ID: 17872348
[TBL] [Abstract][Full Text] [Related]
5. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach toward postmenopausal hyperandrogenism.
Koeneman MM; Heiligers-Duckers C; van der Velde R; Wouda S; de Rooij MJ; Janssen MJ; Boskamp D
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():198-200. PubMed ID: 26950172
[No Abstract] [Full Text] [Related]
7. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
9. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
10. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
Johnson JE; Hussain M; Rathore A; Wolfe K
Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hyperandrogenism of ovarian origin. A clinicopathologic study of four cases.
Honoré LH; Chari R; Mueller HD; Cumming DC; Scott JZ
Gynecol Obstet Invest; 1992; 34(1):52-6. PubMed ID: 1526532
[TBL] [Abstract][Full Text] [Related]
12. [A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].
Witek A; Skałba P; Chełmicki Z; Pajak J
Wiad Lek; 2002; 55(1-2):125-30. PubMed ID: 12043310
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
[TBL] [Abstract][Full Text] [Related]
14. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
15. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
18. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal virilization, simple ovarian cyst, and hilus cell hyperplasia--is there an association?
Braithwaite SS; Bitterman P; DeGeest K; Lebbin DR
Endocr Pract; 2001; 7(1):40-3. PubMed ID: 11250768
[TBL] [Abstract][Full Text] [Related]
20. [Virilization caused by an ovarian tumor. Report of one case].
Salman M P; Cuello F M; Kolbach M; Gejman R; Arteaga U E
Rev Med Chil; 2011 Aug; 139(8):1066-70. PubMed ID: 22215338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
